skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Distribution and reuse of {sup 76}Se-selenosugar in selenium-deficient rats

Journal Article · · Toxicology and Applied Pharmacology
 [1];  [1];  [1]
  1. Department of Toxicology and Environmental Health, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675 (Japan)

Nutritional selenium compounds are transformed to the common intermediate selenide and then utilized for selenoprotein synthesis or excreted in urine mostly as 1{beta}-methylseleno-N-acetyl-DD-galactosamine (selenosugar). Since the biological significance of selenosugar formation is unknown, we investigated their role in the formation of selenoenzymes in selenium deficiency. Rats were depleted of endogenous natural abundance selenium with a single stable isotope ({sup 82}Se) and then made Se-deficient. {sup 76}Se-Selenosugar was administered intravenously to the rats and their urine, serum, liver, kidneys and testes were subjected to speciation analysis with HPLC inductively coupled argon plasma mass spectrometry. Most {sup 76}Se was recovered in its intact form (approximately 80% of dose) in urine within 1 h. Speciation analysis revealed that residual endogenous natural abundance selenium estimated by {sup 77}Se and {sup 78}Se was negligible and distinct distributions of the labeled {sup 76}Se were detected in the body fluids and organs without interference from the endogenous natural abundance stable isotope. Namely, intact {sup 76}Se-selenosugar was distributed to organs after the injection, and {sup 76}Se was used for selenoprotein synthesis. Oxidation to methylseleninic acid and/or hydrolysis of the selenoacetal group to methylselenol were proposed to the transformation of selenosugar for the reuse. Effective use of an enriched stable isotope as an absolute label in hosts depleted of natural abundance isotopes was discussed for application in tracer experiments.

OSTI ID:
20850451
Journal Information:
Toxicology and Applied Pharmacology, Vol. 216, Issue 2; Other Information: DOI: 10.1016/j.taap.2006.05.016; PII: S0041-008X(06)00193-1; Copyright (c) 2006 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0041-008X
Country of Publication:
United States
Language:
English